Multiple Sclerosis Relapsing Remitting clinical trials

Explore recruiting multiple sclerosis relapsing remitting clinical trials.

Recruiting multiple sclerosis relapsing remitting studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Multiple Sclerosis Relapsing Remitting trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Effect of ozanimod on meningeal inflammation and glial activation in Multiple Sclerosis: one year phase 4 experimental study PROTOCOL CODE: OZA22 / IM047 - 048

Italy

Therapeutic use (Phase IV) EU CTIS Study details

Comparative PK, PD, efficacy, safety and immunogenicity assessment of the proposed ocrelizumab biosimilar CYB704 and Ocrevus in participants with relapsing multiple sclerosis (STRIVE-MS)

Croatia, Bulgaria, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Multiple Sclerosis Relapsing Remitting trials by city

Multiple Sclerosis Relapsing Remitting in Toronto Multiple Sclerosis Relapsing Remitting in Vancouver Multiple Sclerosis Relapsing Remitting in Montreal Multiple Sclerosis Relapsing Remitting in Calgary Multiple Sclerosis Relapsing Remitting in Edmonton Multiple Sclerosis Relapsing Remitting in Ottawa Multiple Sclerosis Relapsing Remitting in Winnipeg Multiple Sclerosis Relapsing Remitting in Quebec City Multiple Sclerosis Relapsing Remitting in Hamilton Multiple Sclerosis Relapsing Remitting in Kitchener Multiple Sclerosis Relapsing Remitting in London Multiple Sclerosis Relapsing Remitting in Halifax Multiple Sclerosis Relapsing Remitting in New York Multiple Sclerosis Relapsing Remitting in Los Angeles Multiple Sclerosis Relapsing Remitting in Chicago Multiple Sclerosis Relapsing Remitting in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease